BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29209982)

  • 1. Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients.
    Kim JA; Lim MK; Kim K; Park J; Rhee CK
    Clin Drug Investig; 2018 Apr; 38(4):333-340. PubMed ID: 29209982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
    Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
    Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
    Slade D; Ray R; Moretz C; Germain G; Laliberté F; Shen Q; Duh MS; Mahendran M; Hahn B
    BMC Pulm Med; 2021 Jul; 21(1):253. PubMed ID: 34332555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA.
    Stanford RH; Parker ED; Reinsch TK; Buikema AR; Blauer-Peterson C
    Respir Med; 2019 Apr; 150():1-7. PubMed ID: 30961933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and healthcare utilization among older adults with COPD and depression.
    Albrecht JS; Khokhar B; Huang TY; Wei YJ; Harris I; Moyo P; Hur P; Lehmann SW; Netzer G; Simoni-Wastila L
    Respir Med; 2017 Aug; 129():53-58. PubMed ID: 28732836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.
    Tavakoli H; Johnson KM; FitzGerald JM; Sin DD; Gershon AS; Kendzerska T; Sadatsafavi M
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2003-2013. PubMed ID: 31564848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs.
    Toy EL; Beaulieu NU; McHale JM; Welland TR; Plauschinat CA; Swensen A; Duh MS
    Respir Med; 2011 Mar; 105(3):435-41. PubMed ID: 20880687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD.
    Mäkelä MJ; Backer V; Hedegaard M; Larsson K
    Respir Med; 2013 Oct; 107(10):1481-90. PubMed ID: 23643487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of adherence to inhaled medications among Veterans with COPD.
    Huetsch JC; Uman JE; Udris EM; Au DH
    J Gen Intern Med; 2012 Nov; 27(11):1506-12. PubMed ID: 22782274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
    Hazel-Fernandez L; Louder AM; Foster SA; Uribe CL; Burge RT
    BMC Musculoskelet Disord; 2013 Jan; 14():4. PubMed ID: 23281846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment of COPD: state of the art and real-world analysis of healthcare costs based on medication adherence data.
    Lonigro AS; Ancona D; Liantonio A; Stella P; Procacci C; Germinario A; Bavaro V; Montanaro V; Delle Donne A
    Recenti Prog Med; 2022 Mar; 113(3):202-210. PubMed ID: 35315451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.
    de Miguel-Díez J; Carrasco-Garrido P; Rejas-Gutierrez J; Martín-Centeno A; Gobartt-Vázquez E; Hernandez-Barrera V; Gil de MA; Jimenez-Garcia R
    Lung; 2011 Jun; 189(3):199-206. PubMed ID: 21499887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
    Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
    Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.